NSEDCP
STJ

NJ State Employees Deferred Compensation Plan’s St Jude Medical STJ Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,000
Closed -$401K – 397
2016
Q4 		$401K Hold
5,000
– – 0.08% 287
2016
Q3 		$399K Buy
+5,000
New +$404K 0.08% 287

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's STJ Position: Q1 2017 in Review

NJ State Employees Deferred Compensation Plan sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,000 shares — an estimated $401K sold.

NJ State Employees Deferred Compensation Plan first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $401K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • NJ State Employees Deferred Compensation Plan reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 5,000 St Jude Medical shares in Q1 2017, an estimated $401K.
  • NJ State Employees Deferred Compensation Plan first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • NJ State Employees Deferred Compensation Plan's St Jude Medical position peaked at $401K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2017, filed 27 Apr 2017.